Mehmet Sağlam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mehmet Sağlam has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Figen Narin
Department of Medical Biochemistry School of Medicine Izmir Katip Celebi University Izmir Turkey
5 shared publications - Huriye Erbak Yilmaz
Department of Medical Biochemistry School of Medicine Izmir Katip Celebi University Izmir Turkey
5 shared publications - Levent Savran
Department of Periodontology, Faculty of Dentistry, Izmir Katip Celebi University, Izmir, Turkey
5 shared publications Figen Narin
Department of Medical Biochemistry, School of Medicine, Izmir Katip Celebi University, Izmir, Turkey
4 shared publicationsHuriye Erbak Yılmaz
Department of Medical Biochemistry, School of Medicine, Izmir Katip Celebi University, Izmir, Turkey
4 shared publicationsEmrah Koçak
2 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Springer Nature in BMC Oral Health
Evaluation of salivary Adseverin, DEFA-1 and sRANKL levels in periodontal health and disease: a cross-sectional study
- 7 October 2026
- Published by Springer Nature in BMC Oral Health
Open AccessEvaluation of salivary Adseverin, DEFA-1 and sRANKL levels in periodontal health and disease: a cross-sectional study
- 19 January 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (4) , 1119-1127
Comparative Analysis of Salivary Galectin‐8, Galectin‐9, and RANKL Levels in Periodontal Health and Disease
Objective: This study aimed to compare salivary levels of galectin‐8, galectin‐9, and RANKL in individuals with gingivitis, periodontitis, and healthy periodontium, and to evaluate their diagnostic potential in periodontal diseases. Methods: A total of 60 systemically healthy, non‐smoking individuals were included in this cross‐sectional study. Participants were divided into three groups based on periodontal examination: healthy (Group H, n = 20), gingivitis (Group G, n = 20), and periodontitis (Group P, n = 20). Clinical periodontal parameters were recorded. Salivary biomarker levels were analyzed using ELISA. Results: All biomarkers were significantly elevated in groups G and P compared to group H ( p < 0.05), and higher in group P than group G ( p < 0.05). ROC analysis revealed that galectin‐9 (AUC = 0.946) was significantly better at distinguishing periodontal disease than galectin‐8 (AUC = 0.832) and RANKL (AUC = 0.780) ( p < 0.05). No significant difference was observed between galectin‐8 and RANKL ( p > 0.05). Conclusion: Salivary galectin‐8, galectin‐9, and RANKL levels are elevated in periodontal disease and may serve as diagnostic biomarkers. Among them, galectin‐9 demonstrated superior discriminative power for identifying periodontal disease. Trial Registration: NCT06404476
- 19 January 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (4) , 1119-1127
Comparative Analysis of Salivary Galectin‐8, Galectin‐9, and RANKL Levels in Periodontal Health and Disease
Objective: This study aimed to compare salivary levels of galectin‐8, galectin‐9, and RANKL in individuals with gingivitis, periodontitis, and healthy periodontium, and to evaluate their diagnostic potential in periodontal diseases. Methods: A total of 60 systemically healthy, non‐smoking individuals were included in this cross‐sectional study. Participants were divided into three groups based on periodontal examination: healthy (Group H, n = 20), gingivitis (Group G, n = 20), and periodontitis (Group P, n = 20). Clinical periodontal parameters were recorded. Salivary biomarker levels were analyzed using ELISA. Results: All biomarkers were significantly elevated in groups G and P compared to group H ( p < 0.05), and higher in group P than group G ( p < 0.05). ROC analysis revealed that galectin‐9 (AUC = 0.946) was significantly better at distinguishing periodontal disease than galectin‐8 (AUC = 0.832) and RANKL (AUC = 0.780) ( p < 0.05). No significant difference was observed between galectin‐8 and RANKL ( p > 0.05). Conclusion: Salivary galectin‐8, galectin‐9, and RANKL levels are elevated in periodontal disease and may serve as diagnostic biomarkers. Among them, galectin‐9 demonstrated superior discriminative power for identifying periodontal disease. Trial Registration: NCT06404476
- 19 January 2026
- Published by Wiley in Journal of Periodontology
- Vol. 97 (5) , 907-918
Salivary galectin‐7, galectin‐10, and MMP‐9 levels in periodontally healthy, gingivitis, and periodontitis patients
Background: This study aimed to examine the levels of galectin‐7, galectin‐10, and matrix metalloproteinase‐9 (MMP‐9) in saliva across different periodontal health and disease conditions as well as comparing these biomarkers' discriminative efficiencies in periodontal disease. Methods: A total of 60 systemically healthy nonsmoker participants were enrolled in a cross‐sectional study and divided into healthy (group Hp, n = 20), gingivitis (group G, n = 20), and periodontitis (group P, n = 20) groups based on their periodontal examination results. Whole‐mouth clinical periodontal measurements were recorded. Galectin‐7, galectin‐10, and MMP‐9 levels in the saliva were determined by enzyme‐linked immunosorbent assay (ELISA). Results: The group P had significantly higher saliva galectin‐7 levels than group G and group Hp ( p < 0.05). Periodontal disease groups had higher saliva galectin‐10 levels than the group Hp ( p < 0.05). Group P had the highest MMP‐9 saliva levels compared with the other groups ( p < 0.05). The MMP‐9 levels in group G were also higher than those in the group Hp ( p < 0.05). According to the ROC analysis results, salivary galectin‐7 (AUC = 0.719) and galectin‐10 (AUC = 0.765) had a similar impact on the diagnosis of periodontal disease, while salivary MMP‐9 levels (AUC = 0.899) were found to be more effective in distinguishing periodontal disease compared with other biomarkers. Conclusions: The study's findings suggest that galectin‐7 and galectin‐10 may be helpful and equally efficient biomarkers in the diagnosis of periodontal disease. Compared to these two galectins, MMP‐9 was proven to be a more effective biomarker. Plain language summary: Periodontal disease refers to a group of inflammatory conditions affecting gums and supporting tissues (the bone surrounding the tooth root and the ligaments connecting the tooth to this bone). This disease is divided into two main classes. These are gingivitis (reversible form, characterized by inflammation of the gum without loss of supporting tissues) and periodontitis (advanced, irreversible stage marked by destruction of supporting tissues, leading to potential tooth loss if untreated). The purpose of this study was to investigate the levels of MMP‐9 (an enzyme that plays a major role in tissue remodeling and inflammation, particularly by breaking down collagen and gelatin), galectin‐7 (a protein involved in a variety of biological processes such as immune response and wound healing), and galectin‐10 (a protein having roles in the immune system) in saliva in relation to periodontal health and disease. Subjects with periodontitis had higher levels of all biomolecules and subjects with gingivitis had higher levels of galectin‐10 and MMP‐9 compared with individuals with healthy gums, suggesting that these biomolecules could be involved in the inflammation processes of periodontal disease.
- 19 January 2026
- Published by Wiley in Journal of Periodontology
- Vol. 97 (5) , 907-918
Salivary galectin‐7, galectin‐10, and MMP‐9 levels in periodontally healthy, gingivitis, and periodontitis patients
Background: This study aimed to examine the levels of galectin‐7, galectin‐10, and matrix metalloproteinase‐9 (MMP‐9) in saliva across different periodontal health and disease conditions as well as comparing these biomarkers' discriminative efficiencies in periodontal disease. Methods: A total of 60 systemically healthy nonsmoker participants were enrolled in a cross‐sectional study and divided into healthy (group Hp, n = 20), gingivitis (group G, n = 20), and periodontitis (group P, n = 20) groups based on their periodontal examination results. Whole‐mouth clinical periodontal measurements were recorded. Galectin‐7, galectin‐10, and MMP‐9 levels in the saliva were determined by enzyme‐linked immunosorbent assay (ELISA). Results: The group P had significantly higher saliva galectin‐7 levels than group G and group Hp ( p < 0.05). Periodontal disease groups had higher saliva galectin‐10 levels than the group Hp ( p < 0.05). Group P had the highest MMP‐9 saliva levels compared with the other groups ( p < 0.05). The MMP‐9 levels in group G were also higher than those in the group Hp ( p < 0.05). According to the ROC analysis results, salivary galectin‐7 (AUC = 0.719) and galectin‐10 (AUC = 0.765) had a similar impact on the diagnosis of periodontal disease, while salivary MMP‐9 levels (AUC = 0.899) were found to be more effective in distinguishing periodontal disease compared with other biomarkers. Conclusions: The study's findings suggest that galectin‐7 and galectin‐10 may be helpful and equally efficient biomarkers in the diagnosis of periodontal disease. Compared to these two galectins, MMP‐9 was proven to be a more effective biomarker. Plain language summary: Periodontal disease refers to a group of inflammatory conditions affecting gums and supporting tissues (the bone surrounding the tooth root and the ligaments connecting the tooth to this bone). This disease is divided into two main classes. These are gingivitis (reversible form, characterized by inflammation of the gum without loss of supporting tissues) and periodontitis (advanced, irreversible stage marked by destruction of supporting tissues, leading to potential tooth loss if untreated). The purpose of this study was to investigate the levels of MMP‐9 (an enzyme that plays a major role in tissue remodeling and inflammation, particularly by breaking down collagen and gelatin), galectin‐7 (a protein involved in a variety of biological processes such as immune response and wound healing), and galectin‐10 (a protein having roles in the immune system) in saliva in relation to periodontal health and disease. Subjects with periodontitis had higher levels of all biomolecules and subjects with gingivitis had higher levels of galectin‐10 and MMP‐9 compared with individuals with healthy gums, suggesting that these biomolecules could be involved in the inflammation processes of periodontal disease.
- Open Access
- 22 April 2025
- Published by Springer Nature in Lasers in Medical Science
- Vol. 40 (1) , 1-12
Evaluating efficacy of laser-assisted new attachment procedure and adjunctive low-level laser therapy in treating periodontitis: A single-blind randomized controlled clinical study
Purpose: This study aimed to evaluate the effectiveness of the laser-assisted new attachment procedure (LANAP) and low-level laser therapy (LLLT) on clinical, biochemical, and radiographic parameters when applied alongside scaling and root planing (SRP). Methods: The study was designed as a randomized controlled, single-blind, parallel trial involving 68 patients diagnosed with periodontitis. The participants were divided into three groups: Group 1: SRP (control), Group 2: LANAP, and Group 3: LLLT. Clinical measurements, gingival crevicular fluid (GCF) samples, and standard periapical radiographs were obtained pre-treatment and at one- and three-month follow-ups. In GCF, interleukin-1beta (IL-1β), interleukin-10 (IL-10), and vascular endothelial growth factor (VEGF) were analyzed. Results: In moderate (4–6 mm) and deep pockets (≥ 7 mm), laser-treated groups showed a significant reduction in pocket depth (PD) and clinical attachment level (CAL) compared to the control group. However, there were no statistically significant differences in biochemical markers between the groups. Group 2 demonstrated significant bone filling compared to the control group. Conclusion: In deep pockets, laser-treated groups provide additional benefits to SRP. The application of LLLT positively affected recession (REC). Trial registration number: NCT04694222 Date of registration: 01/01/2021
- 22 April 2025
- Published by Springer Nature in Lasers in Medical Science
- Vol. 40 (1) , 1-12
Open AccessEvaluating efficacy of laser-assisted new attachment procedure and adjunctive low-level laser therapy in treating periodontitis: A single-blind randomized controlled clinical study
Purpose: This study aimed to evaluate the effectiveness of the laser-assisted new attachment procedure (LANAP) and low-level laser therapy (LLLT) on clinical, biochemical, and radiographic parameters when applied alongside scaling and root planing (SRP). Methods: The study was designed as a randomized controlled, single-blind, parallel trial involving 68 patients diagnosed with periodontitis. The participants were divided into three groups: Group 1: SRP (control), Group 2: LANAP, and Group 3: LLLT. Clinical measurements, gingival crevicular fluid (GCF) samples, and standard periapical radiographs were obtained pre-treatment and at one- and three-month follow-ups. In GCF, interleukin-1beta (IL-1β), interleukin-10 (IL-10), and vascular endothelial growth factor (VEGF) were analyzed. Results: In moderate (4–6 mm) and deep pockets (≥ 7 mm), laser-treated groups showed a significant reduction in pocket depth (PD) and clinical attachment level (CAL) compared to the control group. However, there were no statistically significant differences in biochemical markers between the groups. Group 2 demonstrated significant bone filling compared to the control group. Conclusion: In deep pockets, laser-treated groups provide additional benefits to SRP. The application of LLLT positively affected recession (REC). Trial registration number: NCT04694222 Date of registration: 01/01/2021
- Open Access
- 18 February 2025
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 29 (2) , 1-12
Meteorin-like levels of oral fluids in periodontal health and diseases: a comparative cross-sectional study
Objectives: Cytokines are critical role in the pathogenesis of periodontal diseases. Meteorin-like (Metrnl), a protein released in the oral mucosa, is a novel cytokine associated with various inflammatory diseases. This study aimed to evaluate levels of salivary and gingival crevicular fluid (GCF), interleukin − 1 beta (IL-1β), interleukin − 10 (IL-10), and Metrnl in periodontal disease. Materials and methods: It was formed three groups of 20 individuals each: the healthy, gingivitis, and periodontitis (Stage III, Grades A and B) groups. The enzyme-linked immunosorbent assay method measured IL-1β, IL-10, and Metrnl levels in salivary and GCF samples. Clinical periodontal measurement including probing pocket depth (PD), clinical attachment loss (CAL), plaque index (PI), gingival index (GI) and percentage of bleeding on probing (%BOP); and biochemical parameters were evaluated using statistical analysis. Results: Salivary concentrations and GCF total amount of IL-1β were significantly higher in the periodontal disease groups (p < 0.001). There was no significant difference among the groups in either salivary concentrations or GCF total amount of IL-10 (p > 0.05). Salivary Metrnl concentrations were significantly lower in the periodontitis group (p = 0.002). Salivary Metrnl concentrations had significant negative correlations with %BOP, PD, and CAL (p < 0.05). GCF total amount of Metrnl had significant negative correlations with GCF total amount of IL-1β (p = 0.03). The receiver operating characteristics curve showed: area under the curve (AUC) = 0.731 for salivary Metrnl concentrations to discriminate periodontitis from periodontal health and gingivitis. Conclusion: Based on the findings of this study, Metrnl, as an immunoregulatory cytokine, may have an important relationship with periodontitis. Additional studies are needed to fully elucidate the functional effect of Metrnl in periodontal disease. Clinical relevance: Background In knock-out experimental studies, it has been reported that Metrnl acts as an inflammation-related immunoregulatory cytokine. The findings relating it to inflammatory diseases support the idea that Metrnl may play a role in the pathogenesis of a variety of inflammatory diseases. Added value of this study: Although Metrnl is a protein abundantly secreted in the oral mucosa, to the authors’ knowledge there has been no study evaluating it in gingivitis and periodontitis, inflammatory diseases. In this study, the levels of Metrnl in oral fluids, such as GCF and saliva, were examined in the presence of different periodontal diseases. Clinical implications: Metrnl can be useful in distinguishing periodontal destruction from periodontal health.
- 18 February 2025
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 29 (2) , 1-12
Open AccessMeteorin-like levels of oral fluids in periodontal health and diseases: a comparative cross-sectional study
Objectives: Cytokines are critical role in the pathogenesis of periodontal diseases. Meteorin-like (Metrnl), a protein released in the oral mucosa, is a novel cytokine associated with various inflammatory diseases. This study aimed to evaluate levels of salivary and gingival crevicular fluid (GCF), interleukin − 1 beta (IL-1β), interleukin − 10 (IL-10), and Metrnl in periodontal disease. Materials and methods: It was formed three groups of 20 individuals each: the healthy, gingivitis, and periodontitis (Stage III, Grades A and B) groups. The enzyme-linked immunosorbent assay method measured IL-1β, IL-10, and Metrnl levels in salivary and GCF samples. Clinical periodontal measurement including probing pocket depth (PD), clinical attachment loss (CAL), plaque index (PI), gingival index (GI) and percentage of bleeding on probing (%BOP); and biochemical parameters were evaluated using statistical analysis. Results: Salivary concentrations and GCF total amount of IL-1β were significantly higher in the periodontal disease groups (p < 0.001). There was no significant difference among the groups in either salivary concentrations or GCF total amount of IL-10 (p > 0.05). Salivary Metrnl concentrations were significantly lower in the periodontitis group (p = 0.002). Salivary Metrnl concentrations had significant negative correlations with %BOP, PD, and CAL (p < 0.05). GCF total amount of Metrnl had significant negative correlations with GCF total amount of IL-1β (p = 0.03). The receiver operating characteristics curve showed: area under the curve (AUC) = 0.731 for salivary Metrnl concentrations to discriminate periodontitis from periodontal health and gingivitis. Conclusion: Based on the findings of this study, Metrnl, as an immunoregulatory cytokine, may have an important relationship with periodontitis. Additional studies are needed to fully elucidate the functional effect of Metrnl in periodontal disease. Clinical relevance: Background In knock-out experimental studies, it has been reported that Metrnl acts as an inflammation-related immunoregulatory cytokine. The findings relating it to inflammatory diseases support the idea that Metrnl may play a role in the pathogenesis of a variety of inflammatory diseases. Added value of this study: Although Metrnl is a protein abundantly secreted in the oral mucosa, to the authors’ knowledge there has been no study evaluating it in gingivitis and periodontitis, inflammatory diseases. In this study, the levels of Metrnl in oral fluids, such as GCF and saliva, were examined in the presence of different periodontal diseases. Clinical implications: Metrnl can be useful in distinguishing periodontal destruction from periodontal health.
- Open Access
- 20 July 2024
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 28 (8) , 1-10
Clinical effects of omega-3 fatty acids supplementation in the periodontal treatment of smokers and non-smokers with periodontitis: a retrospective study
Objectives: Omega-3 supplementation as an adjunct to nonsurgical periodontal treatment has been reported to have a positive effect on healing in periodontitis patients. However, there is a lack of information on the effects of periodontal healing in smokers with periodontitis. The aim of this retrospective study was to investigate the effect of omega-3 supplementation given as an adjunct to nonsurgical periodontal treatment on clinical parameters in smoker and non-smoker periodontitis patients. Methods: This study included a total of 80 periodontitis patients, 40 non-smokers and 40 smokers who were systemically healthy. In this study, patients were divided into 4 groups as follows: Group 1 (Subgingival instrumentation (SI) alone/nonsmoker), Group 2 (SI alone/smoker), Group 3 (SI + Omega-3/nonsmoker) and Group 4 (SI + Omega-3/smoker). Group 3 and 4 consumed 1320 mg Omega-3 capsule (640 mg EPA, 480 mg DHA) once a day for 3 months. Probing depth (PD), clinical attachment level (CAL), gingival index (GI), plaque index (PI) and bleeding on probing (BOP %) were recorded at baseline, 1 month and 3 months after treatment. Results: Significant improvement of all clinical parameters at 1 and 3 months was observed in all groups. Whole mouth CAL, GI and BOP% were significantly reduced in group 4 compared to group 2 at 1 and 3 months postoperatively (p < 0.05). For moderately deep pockets (4–6 mm) and deep pockets (7 mm≤), PD and CAL reductions were significantly greater in groups taking omega − 3 (group 3 and group 4) compared to groups not taking omega-3 (group 1 and group 2) between baseline and 1 month and between baseline and 3 months (p ˂ 0.05). Conclusion: Omega-3 supplementation given as an adjunct to nonsurgical periodontal treatment provided significant benefit in the improvement of clinical parameters (especially for CAL and PD) in the short term in smokers and non-smokers with periodontitis. Clinical relevance: Nonsurgical periodontal treatment with omega-3 supplementation resulted in significant improvements in clinical parameters in smokers and non-smokers with periodontitis.
- 20 July 2024
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 28 (8) , 1-10
Open AccessClinical effects of omega-3 fatty acids supplementation in the periodontal treatment of smokers and non-smokers with periodontitis: a retrospective study
Objectives: Omega-3 supplementation as an adjunct to nonsurgical periodontal treatment has been reported to have a positive effect on healing in periodontitis patients. However, there is a lack of information on the effects of periodontal healing in smokers with periodontitis. The aim of this retrospective study was to investigate the effect of omega-3 supplementation given as an adjunct to nonsurgical periodontal treatment on clinical parameters in smoker and non-smoker periodontitis patients. Methods: This study included a total of 80 periodontitis patients, 40 non-smokers and 40 smokers who were systemically healthy. In this study, patients were divided into 4 groups as follows: Group 1 (Subgingival instrumentation (SI) alone/nonsmoker), Group 2 (SI alone/smoker), Group 3 (SI + Omega-3/nonsmoker) and Group 4 (SI + Omega-3/smoker). Group 3 and 4 consumed 1320 mg Omega-3 capsule (640 mg EPA, 480 mg DHA) once a day for 3 months. Probing depth (PD), clinical attachment level (CAL), gingival index (GI), plaque index (PI) and bleeding on probing (BOP %) were recorded at baseline, 1 month and 3 months after treatment. Results: Significant improvement of all clinical parameters at 1 and 3 months was observed in all groups. Whole mouth CAL, GI and BOP% were significantly reduced in group 4 compared to group 2 at 1 and 3 months postoperatively (p < 0.05). For moderately deep pockets (4–6 mm) and deep pockets (7 mm≤), PD and CAL reductions were significantly greater in groups taking omega − 3 (group 3 and group 4) compared to groups not taking omega-3 (group 1 and group 2) between baseline and 1 month and between baseline and 3 months (p ˂ 0.05). Conclusion: Omega-3 supplementation given as an adjunct to nonsurgical periodontal treatment provided significant benefit in the improvement of clinical parameters (especially for CAL and PD) in the short term in smokers and non-smokers with periodontitis. Clinical relevance: Nonsurgical periodontal treatment with omega-3 supplementation resulted in significant improvements in clinical parameters in smokers and non-smokers with periodontitis.
- 1 June 2024
- Vol. 55 (6) , 472-481
Comparison of the effect of A-PRF and L-PRF application to palatal donor sites on quality of life and wound healing after free gingival graft surgery
Objectives: This study compared the effects of leukocyte platelet-rich fibrin (L-PRF) and advanced platelet-rich fibrin (A-PRF) on patients' quality of life and the healing of palatal wounds after free gingival graft harvesting. Method and materials: After free gingival graft harvesting, palatal donor sites of 36 patients were assigned to one ofthree groups: L-PRF group, A-PRF group, or palatal stent + periodontal pack group (control group). Wound healing was evaluated by H2O2 test. Pain was evaluated byvisual analog scale and number of analgesics consumed. For patient quality of life, the Oral Health Impact Profile-14 (OH l P-14) questionnaire was utilized. Results: Complete epithelialization was higher in the control group on day 7 than in the test groups (P<.05). Complete epithelialization was achieved in all groups 14days postoperatively. Visual analog scale scores for pain and the number of analgesic tablets consumed were similar in all groups (P> .05). OHIP-14 total scores were similar in all study groups at 7days postoperatively (P>.05). OHIP-14 total and physical pain score was lower in the L-PRF group than the A-PRF group at 14days postoperatively (P<.05). Conclusion: Aside from the slight superiority of L-PRF overA-PRF, it can be concluded that both PRF proceduren have similar effects on palatal wound healing and quality of life.
- 1 June 2024
- Vol. 55 (6) , 472-481
Comparison of the effect of A-PRF and L-PRF application to palatal donor sites on quality of life and wound healing after free gingival graft surgery
Objectives: This study compared the effects of leukocyte platelet-rich fibrin (L-PRF) and advanced platelet-rich fibrin (A-PRF) on patients' quality of life and the healing of palatal wounds after free gingival graft harvesting. Method and materials: After free gingival graft harvesting, palatal donor sites of 36 patients were assigned to one ofthree groups: L-PRF group, A-PRF group, or palatal stent + periodontal pack group (control group). Wound healing was evaluated by H2O2 test. Pain was evaluated byvisual analog scale and number of analgesics consumed. For patient quality of life, the Oral Health Impact Profile-14 (OH l P-14) questionnaire was utilized. Results: Complete epithelialization was higher in the control group on day 7 than in the test groups (P<.05). Complete epithelialization was achieved in all groups 14days postoperatively. Visual analog scale scores for pain and the number of analgesic tablets consumed were similar in all groups (P> .05). OHIP-14 total scores were similar in all study groups at 7days postoperatively (P>.05). OHIP-14 total and physical pain score was lower in the L-PRF group than the A-PRF group at 14days postoperatively (P<.05). Conclusion: Aside from the slight superiority of L-PRF overA-PRF, it can be concluded that both PRF proceduren have similar effects on palatal wound healing and quality of life.
- 21 December 2023
- Published by Wiley in Journal of Periodontal Research
- Vol. 59 (2) , 387-394
The evaluation of salivary leucine‐rich alpha‐2 glycoprotein (LRG) and C‐reactive protein (CRP) in humans with periodontal health or periodontal disease
ObjectiveThe purpose of the present research is to evaluate the salivary levels of leucine-rich alpha-2 glycoprotein (LRG) and C-reactive protein (CRP) in periodontal health and disease (gingivitis and stage III periodontitis) and also to compare the discriminative efficiencies of both biomarkers in periodontal disease.BackgroundLRG is a new acute-phase protein whose functions are still being investigated. LRG and CRP are both biomarkers that are increased by inflammation. No clinical study has yet investigated the comparison of the level of LRG and CRP in periodontal health, gingivitis and periodontitis in saliva samples.MethodsA total of 60 individuals, including 20 periodontally healthy (control group/group C), 20 with gingivitis (group G), and 20 with Stage III periodontitis (group P), who were systemically healthy and non-smokers, participated in this study. Periodontal charts were used for recording clinical periodontal parameters and saliva LRG and CRP levels were measured by ELISA. Analyzing the area under the curve (AUC) was performed by the receiver-operating characteristics curve.ResultsSalivary levels of LRG and CRP were significantly higher in disease groups than in group C (p < .05). Positive statistically significant correlations were observed between both biomarkers and clinical parameters (p < .05). There was also a strong positive correlation between two biomarkers (p < .05). In distinguishing periodontal disease from periodontal health, LRG (AUC = 0.833) and CRP (AUC = 0.826) were found to have similar accuracy (p = .923).ConclusionLRG and CRP may be useful and similarly effective biomarkers in the diagnosis of periodontal diseases based on the findings of this study.
- 21 December 2023
- Published by Wiley in Journal of Periodontal Research
- Vol. 59 (2) , 387-394
The evaluation of salivary leucine‐rich alpha‐2 glycoprotein (LRG) and C‐reactive protein (CRP) in humans with periodontal health or periodontal disease
ObjectiveThe purpose of the present research is to evaluate the salivary levels of leucine-rich alpha-2 glycoprotein (LRG) and C-reactive protein (CRP) in periodontal health and disease (gingivitis and stage III periodontitis) and also to compare the discriminative efficiencies of both biomarkers in periodontal disease.BackgroundLRG is a new acute-phase protein whose functions are still being investigated. LRG and CRP are both biomarkers that are increased by inflammation. No clinical study has yet investigated the comparison of the level of LRG and CRP in periodontal health, gingivitis and periodontitis in saliva samples.MethodsA total of 60 individuals, including 20 periodontally healthy (control group/group C), 20 with gingivitis (group G), and 20 with Stage III periodontitis (group P), who were systemically healthy and non-smokers, participated in this study. Periodontal charts were used for recording clinical periodontal parameters and saliva LRG and CRP levels were measured by ELISA. Analyzing the area under the curve (AUC) was performed by the receiver-operating characteristics curve.ResultsSalivary levels of LRG and CRP were significantly higher in disease groups than in group C (p < .05). Positive statistically significant correlations were observed between both biomarkers and clinical parameters (p < .05). There was also a strong positive correlation between two biomarkers (p < .05). In distinguishing periodontal disease from periodontal health, LRG (AUC = 0.833) and CRP (AUC = 0.826) were found to have similar accuracy (p = .923).ConclusionLRG and CRP may be useful and similarly effective biomarkers in the diagnosis of periodontal diseases based on the findings of this study.
- 3 May 2022
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 26 (8) , 5459-5469
The effectiveness of scaling and root planing with combined application of air polishing and Nd:YAG laser in periodontal pockets of stage III grade C periodontitis patients: a single-blinded randomized clinical trial
Objectives Evaluating the efficiency of combined air polishing and Nd:YAG laser application in addition to scaling and root planning (SRP) in treatment of periodontal pockets of stage III grade C periodontitis patients was the aim of this clinical trial. Materials and methods Twenty-four systemically healthy, stage III grade C periodontitis patients were recruited for this clinical trial. In this split-mouth study, the quadrants were randomly allocated to either SRP with combined air polishing (erythritol/chlorhexidine powder) and Nd:YAG laser (2 W, 200 mJ/pulse, 10 Hz) therapy (test group) or SRP alone (control group). A masked examiner recorded clinical parameters such as plaque index (PI), gingival index (GI), bleeding on probing (%) (BOP %), probing depth (PD), and clinical attachment level (CAL) on periodontal charts at baseline, 1 month and 3 months after treatment. Results The clinical parameters had significantly reduced 1 and 3 months after treatment compared to baseline for both study groups (p < 0.05). Considering PI, GI, and BOP (%) parameters, there were no significant differences between the study groups at any time points (p > 0.05). While PD and CAL reductions were similar in study groups for moderately deep pockets (5 to 6 mm) (p > 0.05), PD and CAL reductions were significantly greater in test group compared to control group for deep pockets (PD ≥ 7 mm) (p < 0.05). Conclusions The present clinical trial demonstrated that SRP with combined application of air polishing and Nd:YAG laser may be advantageous in sites where mechanical debridement alone cannot access, such as deep pockets in the short term. Long-term, well-designed future studies including clinical, biochemical, and microbiological analyses are needed to determine the effectiveness of this procedure. Clinical relevance SRP with combined application of air polishing and Nd:YAG laser provided more reductions in probing depth and clinical attachment level parameters in deep pockets compared to SRP alone.
- 3 May 2022
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 26 (8) , 5459-5469
The effectiveness of scaling and root planing with combined application of air polishing and Nd:YAG laser in periodontal pockets of stage III grade C periodontitis patients: a single-blinded randomized clinical trial
Objectives Evaluating the efficiency of combined air polishing and Nd:YAG laser application in addition to scaling and root planning (SRP) in treatment of periodontal pockets of stage III grade C periodontitis patients was the aim of this clinical trial. Materials and methods Twenty-four systemically healthy, stage III grade C periodontitis patients were recruited for this clinical trial. In this split-mouth study, the quadrants were randomly allocated to either SRP with combined air polishing (erythritol/chlorhexidine powder) and Nd:YAG laser (2 W, 200 mJ/pulse, 10 Hz) therapy (test group) or SRP alone (control group). A masked examiner recorded clinical parameters such as plaque index (PI), gingival index (GI), bleeding on probing (%) (BOP %), probing depth (PD), and clinical attachment level (CAL) on periodontal charts at baseline, 1 month and 3 months after treatment. Results The clinical parameters had significantly reduced 1 and 3 months after treatment compared to baseline for both study groups (p < 0.05). Considering PI, GI, and BOP (%) parameters, there were no significant differences between the study groups at any time points (p > 0.05). While PD and CAL reductions were similar in study groups for moderately deep pockets (5 to 6 mm) (p > 0.05), PD and CAL reductions were significantly greater in test group compared to control group for deep pockets (PD ≥ 7 mm) (p < 0.05). Conclusions The present clinical trial demonstrated that SRP with combined application of air polishing and Nd:YAG laser may be advantageous in sites where mechanical debridement alone cannot access, such as deep pockets in the short term. Long-term, well-designed future studies including clinical, biochemical, and microbiological analyses are needed to determine the effectiveness of this procedure. Clinical relevance SRP with combined application of air polishing and Nd:YAG laser provided more reductions in probing depth and clinical attachment level parameters in deep pockets compared to SRP alone.
- 25 April 2022
- Published by Wiley in Journal of Periodontal Research
- Vol. 57 (4) , 724-732
Gingival crevicular fluid lipocalin‐2 and semaphorin3A in stage III periodontitis: Non‐surgical periodontal treatment effects
Background and Objective: Identification of biomarkers to assess individual risk and monitor periodontal health status is important. Research on lipocalin‐2 (LCN2) and semaphorin3A (Sema3A) is lacking. This study aimed to evaluate gingival crevicular fluid (GCF) LCN2, Sema3A, and tumor necrosis factor‐α (TNF‐α) levels in periodontally healthy (H), gingivitis (G), and periodontitis (P) patients, and their changes following non‐surgical periodontal therapy.Methods: Sixty systemically healthy and non‐smoker participants, diagnosed as periodontally healthy, gingivitis, and stage III grade C periodontitis, were recruited (n = 20/group). Clinical periodontal parameters were recorded and GCF samples were obtained at baseline from all groups; for group P, these were repeated one and three months following non‐surgical periodontal treatment. GCF LCN2, Sema3A, and TNF‐α levels were evaluated with enzyme‐linked immunosorbent assay.Results: GCF LCN2, Sema3A, and TNF‐α total amounts were significantly higher in disease groups than group H (p < .001). Between P and G groups, only TNF‐α levels were significantly different (p < .001). Non‐surgical periodontal therapy resulted in significant improvement of all clinical parameters and significant decreases of GCF LCN2 and TNF‐α levels, at both time points, compared with baseline (p < .001). Sema3A levels remained unchanged following treatment (p > .05). LCN2 and TNF‐α levels were significantly positively correlated with clinical parameters. LCN2 (AUC [area under the curve] = 0.94) and TNF‐α (AUC = 0.98) levels were similarly accurate in differentiating between periodontal disease (whether G or P) and healthy controls.Conclusions: LCN2 and TNF‐α levels in GCF are correlated with clinical parameters and could prove useful as non‐invasive screening tools for periodontitis.
- 25 April 2022
- Published by Wiley in Journal of Periodontal Research
- Vol. 57 (4) , 724-732
Gingival crevicular fluid lipocalin‐2 and semaphorin3A in stage III periodontitis: Non‐surgical periodontal treatment effects
Background and Objective: Identification of biomarkers to assess individual risk and monitor periodontal health status is important. Research on lipocalin‐2 (LCN2) and semaphorin3A (Sema3A) is lacking. This study aimed to evaluate gingival crevicular fluid (GCF) LCN2, Sema3A, and tumor necrosis factor‐α (TNF‐α) levels in periodontally healthy (H), gingivitis (G), and periodontitis (P) patients, and their changes following non‐surgical periodontal therapy.Methods: Sixty systemically healthy and non‐smoker participants, diagnosed as periodontally healthy, gingivitis, and stage III grade C periodontitis, were recruited (n = 20/group). Clinical periodontal parameters were recorded and GCF samples were obtained at baseline from all groups; for group P, these were repeated one and three months following non‐surgical periodontal treatment. GCF LCN2, Sema3A, and TNF‐α levels were evaluated with enzyme‐linked immunosorbent assay.Results: GCF LCN2, Sema3A, and TNF‐α total amounts were significantly higher in disease groups than group H (p < .001). Between P and G groups, only TNF‐α levels were significantly different (p < .001). Non‐surgical periodontal therapy resulted in significant improvement of all clinical parameters and significant decreases of GCF LCN2 and TNF‐α levels, at both time points, compared with baseline (p < .001). Sema3A levels remained unchanged following treatment (p > .05). LCN2 and TNF‐α levels were significantly positively correlated with clinical parameters. LCN2 (AUC [area under the curve] = 0.94) and TNF‐α (AUC = 0.98) levels were similarly accurate in differentiating between periodontal disease (whether G or P) and healthy controls.Conclusions: LCN2 and TNF‐α levels in GCF are correlated with clinical parameters and could prove useful as non‐invasive screening tools for periodontitis.